| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584466 | Experimental and Molecular Pathology | 2017 | 4 Pages |
Abstract
We concluded that PIK3CA mutations and ALK rearrangement occur also in PAEDs, while NRAS mutations might be a very rare event similarly to pulmonary adenocarcinomas of conventional type. KRAS is the prevailing gene mutated in this class of adenocarcinoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Alessia Nottegar, Fabrizio Tabbò, Claudio Luchini, Francesco Guerrera, Marcello Gaudiano, Emilio Bria, Matteo Brunelli, Marco Chilosi, Giorgio Inghirami,